These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 214805)

  • 1. Clinical, neuropathologic and pharmacologic aspects of Huntington's disease: correlates with a new animal model.
    Coyle JT; Schwarcz R; Bennett JP; Campochiaro P
    Prog Neuropsychopharmacol; 1977; 1(1-2):13-30. PubMed ID: 214805
    [No Abstract]   [Full Text] [Related]  

  • 2. Body weight, feeding, and drinking behaviors in rats with kainic acid-induced lesions of striatal neurons--with a note on body weight symptomatology in Huntington's disease.
    Sanberg PR; Fibiger HC
    Exp Neurol; 1979 Dec; 66(3):444-66. PubMed ID: 158536
    [No Abstract]   [Full Text] [Related]  

  • 3. [Toxic action of kainic acid as a model of Huntington chorea and epilepsy (review)].
    Levin SL; Sytinskiĭ IA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(5):754-63. PubMed ID: 6224382
    [No Abstract]   [Full Text] [Related]  

  • 4. Kainic acid: insights from a neurotoxin into the pathophysiology of Huntington's disease.
    Coyle JT; Ferkany JW; Zaczek R
    Neurobehav Toxicol Teratol; 1983; 5(6):617-24. PubMed ID: 6142425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme in substantia nigra: reduction of activity in Huntington's disease and after intrastriatal kainic acid in rats.
    Arregui A; Emson PC; Spokes EG
    Eur J Pharmacol; 1978 Nov; 52(1):121-4. PubMed ID: 214307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activity of dopaminergic neurons of the substantia nigra following lesions of the neostriatum by kainic acid].
    Doudet D; Gross C; Bioulac B
    C R Seances Soc Biol Fil; 1984; 178(3):298-306. PubMed ID: 6238656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On chorea: possible neuronal mechanisms.
    Kanazawa I
    Clin Neurol Neurosurg; 1992; 94 Suppl():S100-2. PubMed ID: 1320477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kainic acid lesions of the striatum in rats mimic the spontaneous motor abnormalities of Huntington's Disease.
    Mason ST; Fibiger HC
    Neuropharmacology; 1979 Apr; 18(4):403-7. PubMed ID: 36573
    [No Abstract]   [Full Text] [Related]  

  • 9. Origin of GABA-ergic strio-nigral neurons as studied by kainate-induced lesions.
    Porceddu ML; Morelli M; Del Fiacco M; Di Chiara G
    Pharmacol Res Commun; 1980 Jul; 12(7):695-8. PubMed ID: 7403239
    [No Abstract]   [Full Text] [Related]  

  • 10. Impaired learning and memory after kainic acid lesions of the striatum: a behavioral model of Huntington's disease.
    Sanberg PR; Lehmann J; Fibiger HC
    Brain Res; 1978 Jun; 149(2):546-51. PubMed ID: 27285
    [No Abstract]   [Full Text] [Related]  

  • 11. Tremor: role of striatal cholinergic neurons and the effect of intrastriatal kainic acid.
    Silbergeld EK; Hruska RE
    Neurosci Lett; 1979 Dec; 15(2-3):235-42. PubMed ID: 530529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABA and benzodiazepine receptors in basal ganglia function.
    Young AB; Pan HS; Ciliax BJ; Penney JB
    Neurosci Lett; 1984 Jun; 47(3):361-7. PubMed ID: 6089057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of content with synthesis, uptake and breakdown of GABA in substantia nigra of unoperated, hemitransected and kainate-treated rats.
    Starr M; Kilpatrick I
    Life Sci; 1981 Nov; 29(22):2281-7. PubMed ID: 7321760
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiotensin converting enzyme in kainic acid--injected striata.
    Singh EA; McGeer EG
    Ann Neurol; 1978 Jul; 4(1):85-6. PubMed ID: 211933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kainic acid lesions of the striatum: behavioural sequalae similar to Huntington's chorea.
    Mason ST; Fibiger HC
    Brain Res; 1978 Oct; 155(2):313-29. PubMed ID: 28817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Denervation supersensitivity in the striatonigral GABA pathway.
    Waddington JL; Cross AJ
    Nature; 1978 Dec; 276(5688):618-20. PubMed ID: 214712
    [No Abstract]   [Full Text] [Related]  

  • 17. Striatal ganglioside levels in the rat following kainic acid lesions: comparison with Huntington's disease.
    Higatsberger MR; Sperk G; Bernheimer H; Shannak KS; Hornykiewicz O
    Exp Brain Res; 1981; 44(1):93-6. PubMed ID: 6456150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]Ro5-4864 benzodiazepine binding in the kainate lesioned striatum and Huntington's diseased basal ganglia.
    Schoemaker H; Morelli M; Deshmukh P; Yamamura HI
    Brain Res; 1982 Sep; 248(2):396-401. PubMed ID: 6291702
    [No Abstract]   [Full Text] [Related]  

  • 19. Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea.
    Coyle JT; Schwarcz R
    Nature; 1976 Sep; 263(5574):244-6. PubMed ID: 8731
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of the substantia nigra in a striatally-evoked motor response in the rat: effects of intranigral drugs and lesions.
    Lee LA; Slater P; Crossman AR
    Neuroscience; 1981; 6(3):359-66. PubMed ID: 6164012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.